Gene E. Alexander mainly focuses on Alzheimer's disease, Dementia, Internal medicine, Pathology and Posterior cingulate. Gene E. Alexander interconnects Brain mapping, Biomarker, Apolipoprotein E, Atrophy and Degenerative disease in the investigation of issues within Alzheimer's disease. His Dementia study integrates concerns from other disciplines, such as Psychiatry, Neuroimaging, Neuropsychological test and Age of onset.
The Internal medicine study combines topics in areas such as Endocrinology, Statistical parametric mapping and Cardiology. His Pathology research focuses on subjects like Positron emission tomography, which are linked to Central nervous system, Senescence and Degeneration. The concepts of his Posterior cingulate study are interwoven with issues in Precuneus and Prefrontal cortex.
His primary scientific interests are in Alzheimer's disease, Internal medicine, Neuroscience, Dementia and Disease. While the research belongs to areas of Alzheimer's disease, Gene E. Alexander spends his time largely on the problem of Posterior cingulate, intersecting his research to questions surrounding Precuneus. His Internal medicine research focuses on Oncology and how it relates to Alzheimer's Disease Neuroimaging Initiative.
His Dementia research is multidisciplinary, incorporating elements of Down syndrome, Psychiatry, Neuropsychological test and Age of onset. His Pathology study combines topics in areas such as Biomarker and Hippocampus. In his study, Neuroimaging, Nuclear medicine and Voxel is inextricably linked to Magnetic resonance imaging, which falls within the broad field of Atrophy.
Gene E. Alexander mainly investigates Cognition, Internal medicine, Physical activity, Apolipoprotein E and Dementia. His Cognition research focuses on Cognitive decline and how it relates to NIH Toolbox, Cohort, Cognitive reserve and Pediatrics. His Internal medicine research incorporates elements of Positron emission tomography, Endocrinology, Magnetic resonance imaging and Cardiology.
In his work, Alzheimer's Disease Neuroimaging Initiative is strongly intertwined with Oncology, which is a subfield of Positron emission tomography. His Dementia research is multidisciplinary, incorporating elements of Alzheimer's disease, Psychiatry, Triage and Telephone interview. Alzheimer's disease is the subject of his research, which falls under Disease.
The scientist’s investigation covers issues in Dementia, Alzheimer's disease, Internal medicine, Apolipoprotein E and Cognition. His Dementia study results in a more complete grasp of Disease. He has researched Alzheimer's disease in several fields, including Hippocampal formation, Hippocampus and Brain size.
The study incorporates disciplines such as Positron emission tomography, Endocrinology, Neuroimaging and Pathology in addition to Internal medicine. His Neuroimaging study integrates concerns from other disciplines, such as Magnetic resonance imaging, Cerebral atrophy, Hyperintensity, Voxel-based morphometry and Cardiology. His Apolipoprotein E study combines topics from a wide range of disciplines, such as Biomarker, Genetics, Posterior cingulate, Allele and Precuneus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.
Clifford R. Jack;Matt A. Bernstein;Nick C. Fox;Paul Thompson.
Journal of Magnetic Resonance Imaging (2008)
Expected performance of the ATLAS experiment - detector, trigger and physics
G. Aad;E. Abat;B. Abbott;J. Abdallah.
Jan 2009. 1852pp. arXiv:0901.0512 (2009)
Expected Performance of the ATLAS Experiment - Detector, Trigger and Physics
G. Aad;E. Abat;B. Abbott.
arXiv: High Energy Physics - Experiment (2008)
ATLAS detector and physics performance : Technical Design Report, 1
A. Airapetian;V. Dodonov;L. Micu;D. Axen.
Other Information: PBD: 18 Jun 1999 (1999)
ATLAS: Technical proposal for a general-purpose p p experiment at the Large Hadron Collider at CERN
W.W. Armstrong;W. Burris;D.M. Gingrich;P. Green.
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
Daniel H. S. Silverman;Gary W. Small;Carol Y. Chang;Carolyn S. Lu.
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Eric M. Reiman;Kewei Chen;Gene E. Alexander;Gene E. Alexander;Richard J. Caselli;Richard J. Caselli.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman;Kewei Chen;Xiaofen Liu;Daniel Bandy.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Search for squarks and gluinos using final states with jets and missing transverse momentum with the ATLAS detector in root s=7 TeV proton-proton collisions
G. Aad;B. Abbott;J. Abdallah;A. A. Abdelalim.
Physics Letters B (2012)
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.
Eric M. Reiman;Richard J. Caselli;Kewei Chen;Gene E. Alexander.
Proceedings of the National Academy of Sciences of the United States of America (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: